Literature DB >> 18624113

[Rho kinase--a new target for pharmacological treatment of an overactive bladder].

Andrzej Wróbel1, Aneta Adamiak, Paweł Skorupski, Tomasz Rechberger.   

Abstract

Rho kinase plays a key role in the regulation of smooth muscles contraction, including those of the urinary bladder detrusor. Rho kinase pathway modulates the level of phosphorylation of the myosin light chain, mainly through the inhibition of myosin phosphatase. Recent experimental data indicate that its role might be exacerbated in local and systemic pathological conditions which affect the bladder. It seems that Rho kinase inhibitors, such as Y27632, may turn out to be an effective group of drugs in pharmacotheraphy of an overactive bladder (OAB), which will influence the storage phase of the micturition cycle, without interfering with the physiological voiding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624113

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  1 in total

1.  Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.

Authors:  Andrzej Wróbel; Urszula Doboszewska; Ewa Rechberger; Karol Rojek; Anna Serefko; Ewa Poleszak; Krystyna Skalicka-Woźniak; Jarosław Dudka; Piotr Wlaź
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-21       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.